CRISPR Therapeutics
CRSP
$53.73
Share price
-3.45%
Change (1 day)
5.19%
Change (1 year)
Operating Margin for CRISPR Therapeutics (CRSP)
Operating Margin as of April 2024 (TTM): -249.11%
According to CRISPR Therapeutics's latest financial reports and stock price the company's current Operating Margin is -249.11%. At the end of 2022 the company had an Operating Margin of -149,197.25%.
Operating Margin history for CRISPR Therapeutics from 2016 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -149,197.25% | -359040.83% |
| 2021 | 41.57% | -100.06% |
| 2020 | -64,098.71% | -275890.36% |
| 2019 | 23.24% | -100.44% |
| 2018 | -5,263.38% | 3139.59% |
| 2017 | -162.47% | -63.07% |
| 2016 | -439.93% | -95.79% |
| 2015 | -10,453.85% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.